IMPACT OF A PATIENT SUPPORT PROGRAM ON INFLAMMATORY BOWEL DISEASE-RELATED HOSPITALIZATION IN PATIENTS TREATED WITH ADALIMUMAB

被引:0
|
作者
Afzali, Anita
Dalal, Sushila
Griffith, Jennifer
Guntaka, Srikar
Padilla, Byron
Wegrzyn, Lani R.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Sa1745
引用
收藏
页码:S406 / S406
页数:1
相关论文
共 50 条
  • [31] The Impact of Hormonal Contraception on Disease-related Cyclical Symptoms in Women with Inflammatory Bowel Diseases
    Gawron, Lori M.
    Goldberger, Adina
    Gawron, Andrew J.
    Hammond, Cassing
    Keefer, Laurie
    INFLAMMATORY BOWEL DISEASES, 2014, 20 (10) : 1729 - 1733
  • [32] Impact of Perceived Social Support on Patients with Inflammatory Bowel Disease
    Jedel, Sharon
    Sohi, Sunana
    Thakkar, Amita
    Kwasny, Mary Morrissey
    Keshavarzian, Ali
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S439 - S439
  • [33] THE IMPACT OF PRIVATE INSURANCE ACCESS ON INFLAMMATORY BOWEL DISEASE-RELATED EMERGENCY DEPARTMENT USE
    Bollegala, Natasha P.
    Nguyen, Geoffrey C.
    GASTROENTEROLOGY, 2017, 152 (05) : S980 - S980
  • [34] Quality of life of patients treated in an Inflammatory Bowel Disease Program in Chile
    Daniela, Simian
    Lilian, Flores
    Rodrigo, Quera
    Patricio, Ibanez
    Jaime, Lubascher
    Carolina, Figueroa
    Gonzalo, Pizarro
    Udo, Kronberg
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S19 - S19
  • [35] The Impact of Participation in an Adalimumab (Humira) Patient Support Program on the Onset and Management of Disease Flares
    van den Bosch, Filip
    Wassenberg, Siegfried
    Haraoui, Boulos
    Zueger, Patrick
    Wu, Meijing
    Galindo, Ivan Lagunes
    Ostor, Andrew
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [36] SOCS3 in immune regulation of inflammatory bowel disease and inflammatory bowel disease-related cancer
    Li, Yi
    de Haar, Colin
    Peppelenbosch, Maikel P.
    van der Woude, C. Janneke
    CYTOKINE & GROWTH FACTOR REVIEWS, 2012, 23 (03) : 127 - 138
  • [37] Therapy outcome related to adalimumab trough levels in pediatric patients with inflammatory bowel disease
    Lehtomaki, Johanna
    Nikkonen, Anne
    Merras-Salmio, Laura
    Hiltunen, Pauliina
    Kolho, Kaija-Leena
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2022, 57 (01) : 31 - 36
  • [38] Prior Antibodies to Infliximab or Adalimumab Are Related to Immunogenicity to Vedolizumab in Patients With Inflammatory Bowel Disease
    Papamichael, Konstantinos
    Vande Casteele, Niels
    Abraham, Bincy P.
    Ritter, Timothy
    Jain, Anjali
    Cheifetz, Adam S.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (11) : 2978 - +
  • [39] Adalimumab and pharmacokinetics:Impact on the clinical prescription for inflammatory bowel disease
    Anne-Laure Pelletier
    Pascale Nicaise-Roland
    World Journal of Pharmacology, 2016, 5 (01) : 44 - 50
  • [40] Family planning in inflammatory bowel disease: childlessness and disease-related concerns among female patients
    Walldorf, Jens
    Brunne, Susanne
    Gittinger, Fleur S.
    Michl, Patrick
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (03) : 310 - 315